Amethyst Pharma Limited
07509862
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/03/2025
total exemption full
Next accounts due
31/12/2026
Confirmation statement
Last: 31/01/2026
Due 14/02/2027
Industry
Officers
director · Since 31/01/2011
PHARMACEUTICAL CONSULTANT
BRITISH · UNITED KINGDOM · Age 61
Also on 1 other board
director · Since 06/04/2017
DIRECTOR
BRITISH · UNITED KINGDOM · Age 64
Also on 2 other boards
Persons with Significant Control
Dr Debra Ellen Nevin
British · United Kingdom · Age 61
13 Sussex Place, Slough, SL1 1NH
Notified 06/04/2016
Mr Diljeet Singh Athwal
British · United Kingdom · Age 64
13 Sussex Place, Slough, SL1 1NH
Notified 01/04/2025
Former PSCs
Mr Diljeet Singh Athwal
Ceased 21/04/2021
CompanyRankvs 6917+ SIC 74909 peers75
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£270k
Balance sheet strength
Cash
£251k
Cash in the bank
Net Current Assets
£263k
Working capital
Current Assets
£279k
Current Liabilities
£15k
Fixed Assets
£9k
Debtors
£28k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 17.99 | -£133k |
| 2024 | 6.70 | +£58k |
| 2023 | 11.38 | — |
Derived from filed accounts. Not audited figures.